AlphaMark Advisors LLC Reduces Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
AlphaMark Advisors LLC lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,685 shares of the biopharmaceutical company’s stock after selling 56 shares during the […]
More Stories
The Hunter Biden Laptop Cover-Up: How Politicians and Spies Influenced a U.S. Election
By Stephen Zogopoulos, USNN World News In the months leading up to the 2020 U.S. Presidential election, the Hunter Biden...
Horizon Bancorp (NASDAQ:HBNC) Reaches New 52-Week High After Dividend Announcement
Horizon Bancorp, Inc. (NASDAQ:HBNC – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday following...
Applied Optoelectronics, Inc. (NASDAQ:AAOI) Given Consensus Rating of “Moderate Buy” by Analysts
Applied Optoelectronics, Inc. (NASDAQ:AAOI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the four...
Endava (NYSE:DAVA) Updates FY 2025 Earnings Guidance
Endava (NYSE:DAVA – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
MillerKnoll (NASDAQ:MLKN) Updates FY 2025 Earnings Guidance
MillerKnoll (NASDAQ:MLKN – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
UMB Financial Co. (NASDAQ:UMBF) Given Average Rating of “Buy” by Brokerages
Shares of UMB Financial Co. (NASDAQ:UMBF – Get Free Report) have earned an average rating of “Buy” from the six...